Strauss S - Search Results

1

Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.

Brennan B, Kirton L, Marec-Bérard P, Gaspar N, Laurence V, Martín-Broto J, Sastre A, Gelderblom H, Owens C, Fenwick N, Strauss S, Moroz V, Whelan J, Wheatley K. Brennan B, et al. Among authors: strauss s. Lancet. 2022 Oct 29;400(10362):1513-1521. doi: 10.1016/S0140-6736(22)01790-1. Lancet. 2022. PMID: 36522207 Clinical Trial.

2

Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.

Strauss SJ, McTiernan A, Driver D, Hall-Craggs M, Sandison A, Cassoni AM, Kilby A, Michelagnoli M, Pringle J, Cobb J, Briggs T, Cannon S, Witt J, Whelan JS. Strauss SJ, et al. J Clin Oncol. 2003 Aug 1;21(15):2974-81. doi: 10.1200/JCO.2003.04.106. J Clin Oncol. 2003. PMID: 12885818

3

Late relapse of osteosarcoma: implications for follow-up and screening.

Strauss SJ, McTiernan A, Whelan JS. Strauss SJ, et al. Pediatr Blood Cancer. 2004 Nov;43(6):692-7. doi: 10.1002/pbc.20154. Pediatr Blood Cancer. 2004. PMID: 15390283

4

Experimental therapies in Ewing's sarcoma.

Windsor R, Strauss S, Seddon B, Whelan J. Windsor R, et al. Among authors: strauss s. Expert Opin Investig Drugs. 2009 Feb;18(2):143-59. doi: 10.1517/13543780802715784. Expert Opin Investig Drugs. 2009. PMID: 19236262 Review.

5

Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma.

Strauss SJ, Ng T, Mendoza-Naranjo A, Whelan J, Sorensen PH. Strauss SJ, et al. Oncologist. 2010;15(6):627-35. doi: 10.1634/theoncologist.2010-0093. Epub 2010 May 17. Oncologist. 2010. PMID: 20479280 Free PMC article. Review.

6

Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.

Windsor RE, Strauss SJ, Kallis C, Wood NE, Whelan JS. Windsor RE, et al. Among authors: strauss sj. Cancer. 2012 Apr 1;118(7):1856-67. doi: 10.1002/cncr.26472. Epub 2011 Sep 1. Cancer. 2012. PMID: 21887680 Free article.

7

Incidence and survival of malignant bone sarcomas in England 1979-2007.

Whelan J, McTiernan A, Cooper N, Wong YK, Francis M, Vernon S, Strauss SJ. Whelan J, et al. Among authors: strauss sj. Int J Cancer. 2012 Aug 15;131(4):E508-17. doi: 10.1002/ijc.26426. Epub 2011 Nov 2. Int J Cancer. 2012. PMID: 21913189 Free article.

8

Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?

Frezza AM, Beale T, Bomanji J, Jay A, Kalavrezos N, Dileo P, Whelan J, Strauss SJ. Frezza AM, et al. BMC Cancer. 2014 Jan 15;14:23. doi: 10.1186/1471-2407-14-23. BMC Cancer. 2014. PMID: 24422949 Free PMC article.

9

What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients.

Rothermundt C, Whelan JS, Dileo P, Strauss SJ, Coleman J, Briggs TW, Haile SR, Seddon BM. Rothermundt C, et al. Among authors: strauss sj. Br J Cancer. 2014 May 13;110(10):2420-6. doi: 10.1038/bjc.2014.200. Epub 2014 Apr 15. Br J Cancer. 2014. PMID: 24736584 Free PMC article.

10

Follow-up practices for high-grade extremity Osteosarcoma.

Rothermundt C, Seddon BM, Dileo P, Strauss SJ, Coleman J, Briggs TW, Haile SR, Whelan JS. Rothermundt C, et al. Among authors: strauss sj. BMC Cancer. 2016 May 6;16:301. doi: 10.1186/s12885-016-2333-y. BMC Cancer. 2016. PMID: 27154292 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,014 results

Search Page